Last reviewed · How we verify
Acetaminophen and codeine and caffeine
Acetaminophen and codeine and caffeine is a Small molecule drug developed by Cairo University. It is currently FDA-approved.
Acetaminophen and codeine and caffeine is a combination of small molecules used to treat acute pain due to trauma and symptomatic irreversible pulpitis. This combination is studied as a preoperative treatment to potentially improve anaesthetic success in patients with acute pulpitis.
At a glance
| Generic name | Acetaminophen and codeine and caffeine |
|---|---|
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Paracetamol Vs Caffeine Vs Codeine in the Management of Post Traumatic Pain in Emergencies (PHASE3)
- Preoperative Acetaminophen- Caffeine- Codeine Combination and Anaesthetic Success in Patients With Acute Pulpitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetaminophen and codeine and caffeine CI brief — competitive landscape report
- Acetaminophen and codeine and caffeine updates RSS · CI watch RSS
- Cairo University portfolio CI
Frequently asked questions about Acetaminophen and codeine and caffeine
What is Acetaminophen and codeine and caffeine?
Who makes Acetaminophen and codeine and caffeine?
What development phase is Acetaminophen and codeine and caffeine in?
Related
- Manufacturer: Cairo University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing